The National Drug Supervision and Administration Work Conference was held in Beijing

On January 5, the National Drug Supervision and Administration Work Conference was held
in Beijing.
The meeting was guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, deeply studied and implemented the spirit of the 20th National Congress of the Communist Party of China, implemented the deployment of the Central Economic Work Conference, summarized the work in 2022 and the past five years, studied and deployed the key tasks of drug supervision modernization in 2023 and the coming period, and mobilized cadres and workers of the whole system to strive to write a new chapter
in the reform and development of drug supervision with full spirit and high morale.

The meeting conveyed State Councilor Wang Yong's important instructions
on drug supervision.
Luo Wen, secretary of the party group and director of the State Administration for Market Regulation, attended and spoke at the meeting, and Yang Yizheng, head of the discipline inspection and supervision team of the Central Commission for Discipline Inspection and the State Supervision Commission in the State Administration for Market Regulation and member of the party group of the State Administration for Market Regulation, attended the meeting
.
Li Li, member of the leading party group of the State Administration for Market Regulation and secretary of the leading party group of the State Food and Drug Administration, and Jiao Hong, director of the State Food and Drug Administration, attended the meeting and delivered speeches
.
Xu Jinghe, Zhao Junning and Huang Guo, members of the party group and deputy directors of the State Food and Drug Administration, drug safety directors of the State Food and Drug Administration, and responsible comrades of the discipline inspection and supervision team stationed in the General Administration attended the meeting
.

The participants unanimously agreed that State Councilor Wang Yong's important instructions fully affirmed the achievements of the national drug supervision work, pinned ardent hopes on the future work, and put forward clear requirements
.
The vast number of cadres and workers of the national drug supervision system are deeply encouraged and excited, and will seriously study and deeply understand, effectively strengthen high-efficiency supervision, ensure high-level safety, promote high-quality development, and constantly create a new situation
in the reform and development of drug supervision.

The meeting reviewed the effectiveness of
drug regulatory work in 2022 and the past five years.
In 2022, the national drug regulatory system conscientiously implemented General Secretary Xi Jinping's "four strictest" requirements, adhered to ensuring safety and guarding the bottom line, promoting development and chasing the high line, coordinated development and safety, coordinated supervision and services, coordinated order and efficiency, and achieved new achievements
in various work.
First, the special rectification project is powerful and effective, and the long-term mechanism has been continuously improved and improved
.
Second, the quality and safety supervision is solid and powerful, and the bottom line
of drug safety is firmly guarded.
The third is to adhere to the people's first and life first, and serve to ensure the overall situation
of epidemic prevention and control.
Fourth, the reform of the review and approval system has continued to deepen, and the pharmaceutical industry has achieved high-quality development
.
Fifth, the supervision capacity has been comprehensively improved, and the regulatory efficiency has been significantly enhanced
.
The work of the past year has brought a successful end to the five years since the establishment of the new drug regulatory system
.
Over the past five years, the national drug regulatory system has taken a clear stand on politics, forged loyalty, and resolutely aligned itself with the Party Central Committee with Comrade Xi Jinping as the core; Unswervingly obey the command, bravely take responsibility, and fully serve to ensure the overall situation of epidemic prevention and control; Do everything possible to prevent risks, ensure safety, and effectively maintain the overall stability of the drug safety situation; Steadily grasp reform, promote innovation, and serve to support the high-quality development of the pharmaceutical industry; Persistently strengthen the system and improve capabilities, and accelerate the modernization of drug supervision; We have made unremitting efforts to grasp party building and consolidate the fundamentals, promote a cleaner political ecology, and make new remarkable achievements
in the reform and development of drug supervision.

The meeting emphasized that to do a good job in drug supervision in the coming period, it is necessary to organically combine the study and implementation of the spirit of the 20th National Congress of the Party with the implementation of the Party Central Committee's drug supervision work policy, consciously put the drug supervision work in the grand scene of promoting the great rejuvenation of the Chinese nation with Chinese-style modernization, and take the road
of Chinese-style drug regulatory modernization.
First, we must stress politics, insist on understanding and viewing drug safety issues from the perspective of safeguarding the authority of the Party Central Committee with Comrade Xi Jinping as the core and from the perspective of consolidating the party's ruling foundation, and earnestly defend the land on the drug supervision front.

Second, we must strengthen supervision, adhere to scientific, rigorous and standardized supervision, implement the drug safety responsibilities of all parties, actively innovate regulatory methods and methods, and comprehensively improve the accuracy and effectiveness
of supervision.
Third, we must ensure safety, strengthen real-time monitoring and early warning, dynamic assessment and control of potential risks, promote the transformation of drug safety management from "passive defense" to "active prevention and control", and build a solid bottom line
of drug safety in an all-round way.
Fourth, we should promote development, give full play to the corrective role of regulatory departments, integrate supervision into services, and accelerate China's progress from a pharmaceutical country to a pharmaceutical power
.
Fifth, it is necessary to benefit the people's livelihood, firmly establish the concept of "supervision for the people", focus on solving practical problems related to the vital interests of the people, and effectively let the people see, feel and feel the results of
drug regulatory reform and development.

The meeting pointed out that 2023 is the first year
to fully implement the spirit of the 20th National Congress of the Communist Party of China.
To do a good job in this year's drug supervision work, we must adhere to the guidance of Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, fully implement the spirit of the 20th National Congress of the Communist Party of China, conscientiously implement the "four strictest" requirements, and solidly promote the modernization of Chinese-style drug supervision in accordance with the work idea of "stressing politics, strengthening supervision, ensuring safety, promoting development, and benefiting people's livelihood", continue to build a solid bottom line of drug safety, deepen drug regulatory reform, improve the efficiency of drug supervision, effectively ensure the safety and effectiveness of people's drug use, and support the high-quality development of the pharmaceutical industry.
Strive to write a new chapter
in drug supervision in building a modern socialist country in an all-round way.

The meeting made arrangements
for drug supervision in 2023.
First, we must abide by the principle and resolutely guard the bottom line
of drug safety.
Service guarantee the epidemic prevention and control work in the new stage, strengthen the quality supervision of epidemic prevention drugs and equipment, support the production and supply of key epidemic prevention drugs and equipment, and continue to do a good job in emergency review and approval; Promote the normalization of special rectification of drug safety with a long-term mechanism, and effectively combat illegal and criminal activities; Continue to improve the vaccine management system to ensure the quality and supply of vaccines; Strengthen the quality and safety supervision of key varieties, adhere to "zero tolerance" for product quality problems, and continue to strengthen the supervision of online sales; Comprehensively strengthen the investigation and resolution of hidden risks, coordinate the use of various means to strengthen safety supervision, and improve pharmacovigilance and emergency management systems
.
The second is reform and innovation to promote the high-quality development of
the pharmaceutical industry.
Promote the creation of a rainforest-type pharmaceutical innovation ecology, accelerate the launch of new drugs and good drugs, promote the R&D and listing of high-end innovative medical devices, release the reform dividend of cosmetics review and approval, and stimulate the vitality of regional pharmaceutical innovation; Promote the inheritance, innovation and development of traditional Chinese medicines, improve the regulatory system of traditional Chinese medicines, improve the review and approval mechanism of traditional Chinese medicines, and strengthen international exchanges and cooperation in traditional medicines; Continue to release the reform dividends of "decentralization, management and service", improve "Internet +" government services, expand the promotion and application of enterprise-related electronic licenses, and further optimize the business environment
.
The third is to base on the long term and comprehensively improve the ability
of drug supervision.
Improve the drug regulatory quality management system, regulatory system, standard system and scientific and technological support system, strengthen technical support capacity building, vigorously develop smart supervision and regulatory science, promote higher levels of openness and higher quality international cooperation, and accelerate the modernization
of the drug regulatory system and regulatory capacity.

The meeting stressed the need to deeply promote the new great project of party building in the new era and continue to do a good job in improving party style and building a clean and honest government and anti-corruption work
.
First, it is necessary to strengthen the party's overall leadership, profoundly understand the decisive significance of the "two establishments," earnestly enhance the "four consciousnesses," strengthen the "four self-confidences," and achieve the "two safeguards.
"
Second, it is necessary to continue to change the style of cadres, encourage party-member cadres to really do solid work, unite and struggle together, and create a good atmosphere
for seeking things, doing things, and accomplishing things.
Third, we must persist in promoting the "three non-corruptions" as a whole, promote the forward movement of supervision and discipline enforcement, firmly establish the cage of the system, deepen education on clean government, and improve the comprehensive efficiency of
anti-corruption and anti-corruption.
Fourth, we should strengthen the training, use, management and supervision of cadres, build a team of high-quality and professional drug supervision cadres, and provide a strong political and organizational guarantee
for the high-quality development of drug supervision.

The meeting was held
by video.
Comrades from relevant departments of the central and state organs were invited to attend the meeting
.
The principal responsible comrades and inspectors of all departments and bureaus of the State Food and Drug Administration, the principal responsible comrades of the party and government directly under the State Food and Drug Administration, members of the leading groups of the drug regulatory departments of various provinces, autonomous regions, municipalities directly under the Central Government and the Xinjiang Production and Construction Corps, and responsible comrades of organs and offices attended the meeting
at the main venue and the sub-venue respectively.